Moffitt Cancer Center study shows improved response rates in myelodysplastic syndromes patients treated with lenalidomide and epoetin alpha
TAMPA, Fla. (Dec. 3, 2016) - Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different ...